Alpesh Shah

Array ( [id] => 6649825 [patent_doc_number] => 20020088017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-04 [patent_title] => 'Adenosine deaminase deficient transgenic mice and methods for the use thereof' [patent_app_type] => new [patent_app_number] => 09/761198 [patent_app_country] => US [patent_app_date] => 2001-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 58366 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20020088017.pdf [firstpage_image] =>[orig_patent_app_number] => 09761198 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6598253 [patent_doc_number] => 20020042385 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-11 [patent_title] => 'Cloning of a novel 7TM receptor AXOR-2' [patent_app_type] => new [patent_app_number] => 09/760354 [patent_app_country] => US [patent_app_date] => 2001-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11240 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20020042385.pdf [firstpage_image] =>[orig_patent_app_number] => 09760354 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6429018 [patent_doc_number] => 20020127200 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-12 [patent_title] => 'Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof' [patent_app_type] => new [patent_app_number] => 09/755633 [patent_app_country] => US [patent_app_date] => 2001-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15181 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20020127200.pdf [firstpage_image] =>[orig_patent_app_number] => 09755633 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6797507 [patent_doc_number] => 20030176381 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Hyaluronic acid in the treatment of cancer' [patent_app_type] => new [patent_app_number] => 10/168327 [patent_app_country] => US [patent_app_date] => 2002-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6571 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20030176381.pdf [firstpage_image] =>[orig_patent_app_number] => 10168327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5905651 [patent_doc_number] => 20020142297 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-03 [patent_title] => 'Compositions and methods for imaging gene expression' [patent_app_type] => new [patent_app_number] => 09/739068 [patent_app_country] => US [patent_app_date] => 2000-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8394 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20020142297.pdf [firstpage_image] =>[orig_patent_app_number] => 09739068 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1073591 [patent_doc_number] => 06838256 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-01-04 [patent_title] => 'Coding sequences of the human BRCA1 gene' [patent_app_type] => utility [patent_app_number] => 09/734672 [patent_app_country] => US [patent_app_date] => 2000-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12896 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/838/06838256.pdf [firstpage_image] =>[orig_patent_app_number] => 09734672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7105358 [patent_doc_number] => 20010004531 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-06-21 [patent_title] => 'AIDS DNA vaccine that prevents SIVmac239 virus infection in monkeys' [patent_app_type] => new-utility [patent_app_number] => 09/730716 [patent_app_country] => US [patent_app_date] => 2000-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6418 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20010004531.pdf [firstpage_image] =>[orig_patent_app_number] => 09730716 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 356152 [patent_doc_number] => 07488588 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-02-10 [patent_title] => 'Compounds related to or derived from GFR α4 and their use' [patent_app_type] => utility [patent_app_number] => 10/203639 [patent_app_country] => US [patent_app_date] => 2000-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 32 [patent_no_of_words] => 24375 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/488/07488588.pdf [firstpage_image] =>[orig_patent_app_number] => 10203639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1255911 [patent_doc_number] => 06667162 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-23 [patent_title] => 'Identification of the gene causing the mouse scurfy phenotype and its human ortholog' [patent_app_type] => B1 [patent_app_number] => 09/697377 [patent_app_country] => US [patent_app_date] => 2000-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 14897 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/667/06667162.pdf [firstpage_image] =>[orig_patent_app_number] => 09697377 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1406046 [patent_doc_number] => 06524573 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-25 [patent_title] => 'Method of suppressing tumor cell growth by administering a decorin gene or gene product' [patent_app_type] => B1 [patent_app_number] => 09/668084 [patent_app_country] => US [patent_app_date] => 2000-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 15 [patent_no_of_words] => 13483 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/524/06524573.pdf [firstpage_image] =>[orig_patent_app_number] => 09668084 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 933963 [patent_doc_number] => 06977158 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-12-20 [patent_title] => 'Mammalian IAP gene family, primers, probes, and detection methods' [patent_app_type] => utility [patent_app_number] => 09/654743 [patent_app_country] => US [patent_app_date] => 2000-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 18 [patent_no_of_words] => 12607 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/977/06977158.pdf [firstpage_image] =>[orig_patent_app_number] => 09654743 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1053099 [patent_doc_number] => 06858426 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-02-22 [patent_title] => 'Grapevine leafroll virus (type 2) proteins and their uses' [patent_app_type] => utility [patent_app_number] => 09/613486 [patent_app_country] => US [patent_app_date] => 2000-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 21 [patent_no_of_words] => 28186 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/858/06858426.pdf [firstpage_image] =>[orig_patent_app_number] => 09613486 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1022189 [patent_doc_number] => 06888047 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-03 [patent_title] => 'Transgenic animals as urinary bioreactors for the production of polypeptide in the urine, recombinant DNA construct for kidney-specific expression, and method of using same' [patent_app_type] => utility [patent_app_number] => 09/605042 [patent_app_country] => US [patent_app_date] => 2000-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 31 [patent_no_of_words] => 14459 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/888/06888047.pdf [firstpage_image] =>[orig_patent_app_number] => 09605042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1593972 [patent_doc_number] => 06491910 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-10 [patent_title] => 'Ovo administration of a competitive exclusion culture' [patent_app_type] => B1 [patent_app_number] => 09/578153 [patent_app_country] => US [patent_app_date] => 2000-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3351 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/491/06491910.pdf [firstpage_image] =>[orig_patent_app_number] => 09578153 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1602526 [patent_doc_number] => 06432705 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-13 [patent_title] => 'Inducible expression system' [patent_app_type] => B1 [patent_app_number] => 09/566660 [patent_app_country] => US [patent_app_date] => 2000-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 17 [patent_no_of_words] => 19577 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/432/06432705.pdf [firstpage_image] =>[orig_patent_app_number] => 09566660 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1565316 [patent_doc_number] => 06376226 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-23 [patent_title] => 'Recombinant, active caspases and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/561756 [patent_app_country] => US [patent_app_date] => 2000-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 42 [patent_no_of_words] => 23644 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/376/06376226.pdf [firstpage_image] =>[orig_patent_app_number] => 09561756 [rel_patent_id] =>[rel_patent_doc_number] =>)